Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder (bibtex)
by Amy B Hart, Eric R Gamazon, Barbara E Engelhardt, Pamela Sklar, Anna K Kähler, Christina M Hultman, Patrick F Sullivan, Benjamin M Neale, Stephen V Faraone, Harriet de Wit, Nancy J Cox, Abraham a Palmer
Reference:
Amy B Hart, Eric R Gamazon, Barbara E Engelhardt, Pamela Sklar, Anna K Kähler, Christina M Hultman, Patrick F Sullivan, Benjamin M Neale, Stephen V Faraone, Harriet de Wit, Nancy J Cox, Abraham a Palmer. Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder, Proceedings of the National Academy of Sciences of the United States of America, 111(16):5968--73, 2014.
Bibtex Entry:
@article{Hart2014,
author = {Hart, Amy B and Gamazon, Eric R and Engelhardt, Barbara E and Sklar, Pamela and K\"{a}hler, Anna K and Hultman, Christina M and Sullivan, Patrick F and Neale, Benjamin M and Faraone, Stephen V and de Wit, Harriet and Cox, Nancy J and Palmer, Abraham a},
doi = {10.1073/pnas.1318810111},
url = {http://www.cs.princeton.edu/~bee/pubs/Hart-PNAS-2014.pdf},
issn = {1091-6490},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
month = apr,
number = {16},
pages = {5968--73},
pmid = {24711425},
title = {{Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder}},
volume = {111},
year = {2014}
}
Powered by bibtexbrowser